Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 31. Juli 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9021  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 180415  
   
Apalutamide-induced prostate-specific antigen response and its association with clinical outcomes in metastatic castration sensitive prostate cancer (Review).
Mol Clin Oncol
N S, Mv C, Upadhyay A, Sonone P, Dharmadhikari S, Puppalwar G, Khandhedia C, Mane A, Mehta S.
PMID: 42534213 [PubMed - in process]


[(18)F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer.
Int J Urol
Hatano K, Watabe T, Hirata T, Konishi M, Kanaki T, Tani M, Oka T, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Fujita K, Uemura M, Giesel FL, Nonomura N.
PMID: 42533777 [PubMed - indexed for MEDLINE]


Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population.
Int J Urol
Matsushita Y, Kita Y, Mukai S, Joraku A, Kobayashi I, Daizumoto K, Sano T, Nakanishi S, Watanabe J, Hatakeyama S, Goriki A, Hazama T, Nishiyama N, Mori K, Kitamura H, Kimura T, Matsui Y, Miyake M, Kobayashi T, Inamoto T, Japanese Urological Oncology Group.
PMID: 42533764 [PubMed - indexed for MEDLINE]


Full-Component Chart-Derived Lee Score, Upfront Androgen Receptor Signaling Inhibitor Selection, and Competing Mortality in Metastatic Hormone-Sensitive Prostate Cancer.
Geriatr Gerontol Int
Kurokawa K, Yamamoto S, Higa K, Bamba H, Kanaoka S, Nakamura K.
PMID: 42533722 [PubMed - indexed for MEDLINE]


Challenges of Bone Scintigraphy in Assessment of Osseous Metastases in Prostate Cancer: Why it is Time to Reconsider Role of (1)â¸F-NaF PET/CT.
Mol Imaging Biol
Zirakchian Zadeh M.
PMID: 42533239 [PubMed - as supplied by publisher]


Tumor and Organ Dose Estimates from (177)Lu-PSMA-617 Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: Results from the RESIST-PC Phase 2 Trial.
J Nucl Med
Ells Z, Meyer C, Masri K, Ryhiner M, Sennung D, Kimura K, Mirando D, Tworowska I, Esfandiari R, Allen-Auerbach MS, Lassmann M, Herrmann K, Eiber M, Fendler WP, Delpassand E, Czernin J, Dahlbom M, Calais J.
PMID: 42532646 [PubMed - as supplied by publisher]


Environmental exposome study for prostate cancer in elderly men from Western China: preliminary findings from a case-control study in the WeEndPd cohort.
BMJ Open
Zhou X, He Y, Jin Y, Peng Z, Zeng B, Zhang Z, Wu Y, Wei C, Mo Z, Cheng J, Chen Y, Wang F, Lu G, Tao K, Yang Z, Wu Y, Zhang W, Zhuang C, Guo W, Li G, Liu Y, Huang Y, Gao R, Zhan Y, Zou X, Yang L, Wei Q, Wei X, Qiu S.
PMID: 42532568 [PubMed - indexed for MEDLINE]


[Testicular Germ Cell Tumors and Penile Cancer: Molecular-Based Diagnosis and Treatment].
Aktuelle Urol
Paffenholz P, Heidenreich A, Weiten R.
PMID: 42532107 [PubMed - as supplied by publisher]


Can prostate cancer be diagnosed with near certainty on MRI?
Eur J Radiol
Cummings C, Allen C, Dickinson L, Pendse D, Emberton M, Giganti F, Moore C, Woernle A, Freeman A, Haider A, Kirkham A.
PMID: 42531699 [PubMed - as supplied by publisher]


Assessing Geographic Disparities in the Availability of Renal Cell Carcinoma Clinical Trials in the United States.
JCO Oncol Pract
Zhang G, Fann J, Castro DV, Shah KU, Li X, Abreu de Goes V, Jaime-Casas S, Mercier B, Li YJ, Agarwal R, Dickter S, Dukkipati A, Goud J, Lau L, Lau LM, Lee J, Shah K, Simon R, Swarat E, Zugman M, Moradi A, Hsu J, Dizman N, Nguyen C, Chehrazi-Raffle A, Barragan-Carrillo R, Pal SK.
PMID: 42531525 [PubMed - as supplied by publisher]


Prognostic significance of TOP2A expression in bladder cancer: Systematic review and meta-analysis.
Can Urol Assoc J
Hendri AZ, Robert R, Febriyanto T, Liliana B, Pratama ADM, Oey O.
PMID: 42531453 [PubMed - as supplied by publisher]


Association between time from diagnosis to radical cystectomy and oncologic outcomes in muscle-invasive urothelial carcinoma of the bladder.
Can Urol Assoc J
Kim P, Kaul S, Fleishman A, Perez-Londono A, Kim S, Bellmunt J, Aghdam N, Olumi AF, Chang P, Wagner A, Gershman B.
PMID: 42531446 [PubMed - as supplied by publisher]


Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.
Clin Cancer Res
Zhao SG, Holmberg E, Lundstedt D, Killander F, Niméus E, Sharifi M, Sjöström M, Karlsson P.
PMID: 42531378 [PubMed - as supplied by publisher]


Concurrent Jackstone Calculus and Prostate Cancer: Should They Be Treated Concurrently or Sequentially?
Am J Mens Health
Tian S, Li H, Jiang Y, Wang C, Liu S, Wu F, Ning H.
PMID: 42531155 [PubMed - indexed for MEDLINE]


Patient-Provider Communication and Treatment Decision-Making among Latino Men with Prostate Cancer: A Qualitative Study.
J Racial Ethn Health Disparities
Rodriguez VE, Mendoza-Aguayo B, Rodriguez J, Ramirez CM, Soto D, Unger JB, Abreu AL, Ariani R, Baezconde-Garbanati L, Ballas L, Stern MC.
PMID: 42530811 [PubMed - as supplied by publisher]


Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches.
Cell Biol Int
Sayed U, Basheer NM, H M, Nayak PP, Shankhyan A, Eshmetov R, Sadikova S, Ataullaev Z.
PMID: 42529891 [PubMed - indexed for MEDLINE]


Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics.
Front Immunol
Zhang Z, He L, Chen B, Zhang H.
PMID: 42529102 [PubMed - indexed for MEDLINE]


PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing.
Oncol Rev
Gierulska N, Jankowska N, Kwiatkowska A, Kuchno P, , Szklener K, Ko, Skórzewska M.
PMID: 42529062 [PubMed]


Awareness, risk perception, and attitudes toward prostate cancer detection and MRI among Armenian men.
Front Public Health
Shalunc NN, Gaboyan SS, Matinyan NG, Mnatsakanyan TS, Hovhannisyan MG, Ergas IJ.
PMID: 42529047 [PubMed - indexed for MEDLINE]


Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab.
Front Immunol
Bonatto ME, Dvo, Kollár M, Girsa D, Pr, Forejtová , Mann H, Vencovský J, Pavelka K, .
PMID: 42528919 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 180415    Seite 1 von 9021  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1